Addict Sci Clin Pract 2016, 11(Suppl 1):13 DOI 10.1186/s13722-016-0062-9
MEETING ABSTRACTS
Addiction Science & Clinical Practice Open Access
Proceedings of the 13th annual conference of INEBRIA Lausanne, Switzerland. 22–23 September 2016 Published: 19 September 2016 A1 Service evaluation of alcohol identification and brief advice (IBA) direct to the public in a novel setting Rod Watson1, James Morris2, John Isitt3 1 Health Innovation Network, London, SE1 9BB, UK; 2Alcohol Academy, London, SM5 2PS, UK; 3Resonant, London, W1D 6HW, UK Correspondence: Rod Watson - [email protected] Addiction Science & Clinical Practice 2016, 11(Suppl 1): A1 Background: Many young people in England do not use services associated with delivery of alcohol IBA (also called screening and brief intervention). The project tested whether IBA can be delivered to 18–30 year-old, on busy city streets, by trained workers who were not healthcare professionals, without framing it as an ‘alcohol reduction’ intervention. This approach may be referred to as ‘IBA Direct’. Materials and methods: Numbers of participants in the intervention were recorded on a monitoring sheet, along with the individual’s gender, age and AUDIT score. The evaluator asked some participants to complete a brief, anonymous feedback form about their experience of the intervention. Results: The project was delivered over 3 days, amassing a total of 24 h across 2 Saturdays and 1 Sunday in August 2015. Four workers were present on all days. In total, 402 brief interventions were completed; however, data from 379 participants were recorded. Forty-one percent were female (21 % missing data) and 42 % were aged in their teens or twenties. A participant feedback form was completed by 61 people. Ninety-three percent (n = 57) rated the service as ‘Excellent’ or ‘Good’. All respondents who answered the question on the suitability of the setting of the service (n = 58) said it was suitable. Nine out of ten respondents (n = 55) stated they would participate in this service in a public setting again. Conclusions: The evaluation of this project has demonstrated the feasibility and high acceptability of IBA Direct being delivered by non-health workers to the public on the streets of London. There were high levels of engagement at each location and among those aged 18–30. Important facilitators were considered to be the ‘branding’ of the intervention and materials, for example, framed as a ‘health quiz’ not ‘alcohol reduction’ and incentives to draw people in such as free ‘mocktails’ (soft drinks). A2 Innovative support for the patient with alcohol dependence (SIDEAL): Pilot study of a mobile app for alcohol dependence Pablo Barrio1, Lluisa Ortega2, Antoni Gual1 1 GRAC, Addictions Unit, Department of Psychiatry, Clinical Institute of Neuroscience, Hospital Clínic, Barcelona, Barcelona, 08036, Spain; 2 Fundació Clínic Recerca Biomèdica (FCRB), RETICS (Red de Trastornos adictivos), University of Barcelona, Barcelona, 08036, Spain Correspondence: Pablo Barrio - [email protected] Addiction Science & Clinical Practice 2016, 11(Suppl 1): A2
Background: Information and Communication Technologies (ICT) have opened new possibilities in the field of alcohol dependence (AD). In particular, mobile applications (APPs) could provide some relevant improvements in the management of AD, as has been shown in previous studies. The aim of this study is to report the results of a pilot study testing the usability and satisfaction of a mobile APP (called SIDEAL) in AD patients. Materials and methods: Adult, outpatient subjects with AD were included. SIDEAL was installed on patients’ own phones. The Time Line Follow-Back (TLFB) for the preceding 6 weeks was administered both at baseline and after 6 weeks (study end). Self-reports from the app were also assessed at study end and compared to data provided by the TLFB. An online questionnaire about usability and satisfaction was surveyed to participants after study completion. Exploratory efficacy analyses were conducted. Patients kept their usual treatment. Results: 29 patients were included (mean age 48 (SD 11.3), women 50 %) Of these, 2 never used the APP and 3 only used it in the initial visit, and were excluded from analysis. Most patients (22/24) chose a consumption reduction aim, with 11 patients receiving nalmefene. Patients used the self-register module of the APP on average 80 % of days. The most valued modules were the consumption and medication self-register ones, as well as the weekly feedback provided by the APP about weekly rate of usage. Satisfaction was high. Significant reductions were observed in alcohol consumption (binge drinking days in the last 6 weeks declined from 25 (SD 18.6) to 5.8 (SD 8), p
MEETING ABSTRACTS
Addiction Science & Clinical Practice Open Access
Proceedings of the 13th annual conference of INEBRIA Lausanne, Switzerland. 22–23 September 2016 Published: 19 September 2016 A1 Service evaluation of alcohol identification and brief advice (IBA) direct to the public in a novel setting Rod Watson1, James Morris2, John Isitt3 1 Health Innovation Network, London, SE1 9BB, UK; 2Alcohol Academy, London, SM5 2PS, UK; 3Resonant, London, W1D 6HW, UK Correspondence: Rod Watson - [email protected] Addiction Science & Clinical Practice 2016, 11(Suppl 1): A1 Background: Many young people in England do not use services associated with delivery of alcohol IBA (also called screening and brief intervention). The project tested whether IBA can be delivered to 18–30 year-old, on busy city streets, by trained workers who were not healthcare professionals, without framing it as an ‘alcohol reduction’ intervention. This approach may be referred to as ‘IBA Direct’. Materials and methods: Numbers of participants in the intervention were recorded on a monitoring sheet, along with the individual’s gender, age and AUDIT score. The evaluator asked some participants to complete a brief, anonymous feedback form about their experience of the intervention. Results: The project was delivered over 3 days, amassing a total of 24 h across 2 Saturdays and 1 Sunday in August 2015. Four workers were present on all days. In total, 402 brief interventions were completed; however, data from 379 participants were recorded. Forty-one percent were female (21 % missing data) and 42 % were aged in their teens or twenties. A participant feedback form was completed by 61 people. Ninety-three percent (n = 57) rated the service as ‘Excellent’ or ‘Good’. All respondents who answered the question on the suitability of the setting of the service (n = 58) said it was suitable. Nine out of ten respondents (n = 55) stated they would participate in this service in a public setting again. Conclusions: The evaluation of this project has demonstrated the feasibility and high acceptability of IBA Direct being delivered by non-health workers to the public on the streets of London. There were high levels of engagement at each location and among those aged 18–30. Important facilitators were considered to be the ‘branding’ of the intervention and materials, for example, framed as a ‘health quiz’ not ‘alcohol reduction’ and incentives to draw people in such as free ‘mocktails’ (soft drinks). A2 Innovative support for the patient with alcohol dependence (SIDEAL): Pilot study of a mobile app for alcohol dependence Pablo Barrio1, Lluisa Ortega2, Antoni Gual1 1 GRAC, Addictions Unit, Department of Psychiatry, Clinical Institute of Neuroscience, Hospital Clínic, Barcelona, Barcelona, 08036, Spain; 2 Fundació Clínic Recerca Biomèdica (FCRB), RETICS (Red de Trastornos adictivos), University of Barcelona, Barcelona, 08036, Spain Correspondence: Pablo Barrio - [email protected] Addiction Science & Clinical Practice 2016, 11(Suppl 1): A2
Background: Information and Communication Technologies (ICT) have opened new possibilities in the field of alcohol dependence (AD). In particular, mobile applications (APPs) could provide some relevant improvements in the management of AD, as has been shown in previous studies. The aim of this study is to report the results of a pilot study testing the usability and satisfaction of a mobile APP (called SIDEAL) in AD patients. Materials and methods: Adult, outpatient subjects with AD were included. SIDEAL was installed on patients’ own phones. The Time Line Follow-Back (TLFB) for the preceding 6 weeks was administered both at baseline and after 6 weeks (study end). Self-reports from the app were also assessed at study end and compared to data provided by the TLFB. An online questionnaire about usability and satisfaction was surveyed to participants after study completion. Exploratory efficacy analyses were conducted. Patients kept their usual treatment. Results: 29 patients were included (mean age 48 (SD 11.3), women 50 %) Of these, 2 never used the APP and 3 only used it in the initial visit, and were excluded from analysis. Most patients (22/24) chose a consumption reduction aim, with 11 patients receiving nalmefene. Patients used the self-register module of the APP on average 80 % of days. The most valued modules were the consumption and medication self-register ones, as well as the weekly feedback provided by the APP about weekly rate of usage. Satisfaction was high. Significant reductions were observed in alcohol consumption (binge drinking days in the last 6 weeks declined from 25 (SD 18.6) to 5.8 (SD 8), p
